Application 203533

Type
ANDA
Sponsor
MACLEODS PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RISEDRONATE SODIUMRISEDRONATE SODIUMTABLET;ORAL5MGNoNo
002RISEDRONATE SODIUMRISEDRONATE SODIUMTABLET;ORAL30MGNoNo
003RISEDRONATE SODIUMRISEDRONATE SODIUMTABLET;ORAL35MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
33342-107Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-107Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-107Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-107Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-108Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-108Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-108Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-108Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-109Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-109Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-109Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent
33342-109Risedronate SodiumRisedronate SodiumMacleods Pharmaceuticals LimitedANDACurrent